Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor VIII inhibitor postpartum.

J J Michiels, L J Bosch, P M van der Plas

    Scandinavian Journal of Haematology
    |February 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward.

    International angiology : a journal of the International Union of Angiology·2014
    Same author

    Effect of nitrous oxide on folate coenzyme distribution and de novo synthesis of thymidylate in human bone marrow cells.

    Toxicology in vitro : an international journal published in association with BIBRA·2010
    Same author

    Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.

    Hematology (Amsterdam, Netherlands)·2007
    Same author

    JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature.

    Annals of hematology·2007
    Same author

    A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.

    Leukemia·2007

    Acquired factor VIII deficiency in postpartum women due to inhibitors is rare. Treatment with factor VIII concentrate is often successful, and spontaneous remission is common.

    Area of Science:

    • Hematology
    • Immunology

    Background:

    • Acquired factor VIII deficiency in postpartum women due to inhibitors is a rare condition with unknown etiology.
    • This condition presents a hemorrhagic diathesis similar to classic hemophilia, but with increased frequency of ecchymoses and tissue bleeding.

    Observation:

    • The inhibitor potency can range from weak to strong.
    • Inactivation of factor VIII coagulant activity (factor VIII-C) by the inhibitor follows a non-linear pattern.
    • While severe bleeding can be fatal, factor VIII concentrate substitution is generally effective without triggering an anamnestic response in inhibitor activity.

    Findings:

    • The study reviews a case report and existing literature on acquired factor VIII inhibitors in postpartum women.
    • Factor VIII concentrate substitution is effective for managing bleeding symptoms.

    Related Experiment Videos

  • Immunosuppression lacks convincing evidence of efficacy, likely due to the condition's natural history of spontaneous inhibitor disappearance.
  • Implications:

    • Factor VIII concentrate should be used for bleeding symptoms, not exclusively for life-threatening hemorrhages.
    • Understanding the non-linear inactivation and spontaneous remission is crucial for patient management.
    • Further research into the etiology of acquired factor VIII inhibitors in this population is warranted.